Cardiovascular Revascularization Medicine
Volume 8, Issue 2 , Pages 84-89 , April 2007

Treatment of unprotected left main disease with drug-eluting stents in patients at high risk for coronary artery bypass grafting

  • Peter Barlis

      Affiliations

    • Department of Cardiology, Austin Hospital, Melbourne, Victoria 3084, Australia
    • ,
  • Mark Horrigan

      Affiliations

    • Department of Cardiology, Austin Hospital, Melbourne, Victoria 3084, Australia
    • ,
  • Safari Elis

      Affiliations

    • Department of Cardiology, Austin Hospital, Melbourne, Victoria 3084, Australia
    • ,
  • Robert Chan

      Affiliations

    • Department of Cardiology, Austin Hospital, Melbourne, Victoria 3084, Australia
    • ,
  • Michael Wong

      Affiliations

    • Department of Cardiology, Austin Hospital, Melbourne, Victoria 3084, Australia
    • ,
  • Omar Farouque

      Affiliations

    • Department of Cardiology, Austin Hospital, Melbourne, Victoria 3084, Australia
    • ,
  • George Proimos

      Affiliations

    • Department of Cardiology, Austin Hospital, Melbourne, Victoria 3084, Australia
    • ,
  • Andrew E. Ajani

      Affiliations

    • NHMRC Cardiovascular Center of Research Excellence, Melbourne, Australia
    • ,
  • David J. Clark

      Affiliations

    • Department of Cardiology, Austin Hospital, Melbourne, Victoria 3084, Australia
    • Corresponding Author InformationCorresponding author. Department of Cardiology, Austin Hospital, PO Box 5555, Heidelberg, Victoria 3084, Australia. Tel.: +61 3 9496 5527; fax: +61 3 9459 0971.

Received 15 October 2006 ,Accepted 28 November 2006.

References 

  1. Park SJ, Kim YH, Lee BK, Lee SW, Lee CW, Hong MK, et al. Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis: comparison with bare metal stent implantation. J Am Coll Cardiol. 2005;45:351–356
  2. Takagi T, Stankovic G, Finci L, Toutouzas K, Chieffo A, Spanos V, et al. Results and long-term predictors of adverse clinical events after elective percutaneous interventions on unprotected left main coronary artery. Circulation. 2002;106:698–702
  3. Tan WA, Tamai H, Park SJ, Plokker HW, Nobuyoshi M, Suzuki T, et al. Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients. Circulation. 2001;104:1609–1614
  4. Ellis SG, Tamai H, Nobuyoshi M, Kosuga K, Colombo A, Holmes DR, et al. Contemporary percutaneous treatment of unprotected left main coronary stenoses: initial results from a multicenter registry analysis 1994–1996. Circulation. 1997;96:3867–3872
  5. Black A, Cortina R, Bossi I, Choussat R, Fajadet S, Marco J. Unprotected left main coronary artery stenting: correlates of midterm survival and impact of patient selection. J Am Coll Cardiol. 2001;37:832–838
  6. Marso SP, Steg G, Plokker T, Holmes D, Park SJ, Kosuga K, et al. Catheter-based reperfusion of unprotected left main stenosis during an acute myocardial infarction (the ULTIMA experience). Unprotected Left Main Trunk Intervention Multi-center Assessment. Am J Cardiol. 1999;83:1513–1517
  7. Agostoni P, Valgimigli M, Van Mieghem CA, Rodriguez-Granillo GA, Aoki J, Ong AT, et al. Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug-eluting stent era with versus without intravascular ultrasonic guidance. Am J Cardiol. 2005;95:644–647
  8. Chieffo A, Stankovic G, Bonizzoni E, Tsagalou E, Iakovou I, Montorfano M, et al. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation. 2005;111:791–795
  9. Valgimigli M, van Mieghem CA, Ong AT, Aoki J, Granillo GA, McFadden EP, et al. Short- and long-term clinical outcome after drug-eluting stent implantation for the percutaneous treatment of left main coronary artery disease: insights from the Rapamycin-Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries (RESEARCH and T-SEARCH). Circulation. 2005;111:1383–1389
  10. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European System for Cardiac Operative Risk Evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16:9–13
  11. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315–1323
  12. Schofer J, Schluter M, Gershlick AH, Wijns W, Garcia E, Schampaert E, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomized controlled trial (E-SIRIUS). Lancet. 2003;362:1093–1099
  13. Colombo A, Orlic D, Stankovic G, Corvaja N, Spanos V, Montorfano M, et al. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation. 2003;107:2178–2180
  14. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. A polymer based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221–231
  15. White HD, Assmann SF, Sanborn TA, Jacobs AK, Webb JG, Sleeper LA, et al. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial. Circulation. 2005;112:1992–2001
  16. Arampatzis CA, Lemos PA, Tanabe K, Hoye A, Degertekin M, Saia F, et al. Effectiveness of sirolimus-eluting stent for treatment of left main coronary artery disease. Am J Cardiol. 2003;92:327–329
  17. Caracciolo EA, Davis KB, Sopko G, Kaiser GC, Corley SD, Schaff H, et al. Comparison of surgical and medical group survival in patients with left main coronary artery disease. Long-term CASS experience. Circulation. 1995;91:2335–2344
  18. Smith SC, Feldman TE, Hirshfeld JW, Jacobs AK, Kern MJ, King SB, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention—summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation. 2006;113:156–175
  19. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. N Engl J Med. 1999;341:625–634

PII: S1553-8389(06)00263-6

doi: 10.1016/j.carrev.2006.11.007

Cardiovascular Revascularization Medicine
Volume 8, Issue 2 , Pages 84-89 , April 2007

Article Tools

* Image Usage & Resolution